Hantaan/Puumala virus DNA vaccine (USAMRIID)

N/A

Report date: 2022/12/27 09:23:07

Base Information

Drug NameHantaan/Puumala virus DNA vaccine (USAMRIID)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHemorrhagic Fevers, Viral

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUS Army Medical Research Institute of Infectious Diseases

China Registration ClassN/A

Develop Information

Active CompaniesUS Army Medical Research Institute of Infectious Diseases

Inactive CompaniesN/A

Active IndicationsHemorrhagic Fevers, Viral

Inactive IndicationsN/A

Other Information

ATC CodeN/A